Skip to main content

Table 3 Distribution of risk factors proposed to contribute to prolonged disease course and, or severity in both intervention groups

From: Nebulised hypertonic saline (3 %) among children with mild to moderately severe bronchiolitis - a double blind randomized controlled trial

Variables 3 % HS + L-Epi 0.9 % NS + L-Epi p-value
(n = 50) (n = 50)
Family history of asthma, n (%) 4 (8.0) 5 (10.0) 1.00
Parental smoking, n (%) 30 (60.0) 21 (42.0) 0.05
Exposure to biofuels, n (%) 14 (28.0) 8 (16.0) 0.11
Breastfeeding status, n (%) 48 (96.0) 48 (96.0) 0.75
Prematurity, n (%) 3 (6.0) 2 (4.0) 0.50
Atopic history, n (%) 7 (14.0) 3 (6.0) 0.15